Trial Section
Home / Trial Section / Clinical Trial| Indication | Department | Study Title | Study Phase | Investigator | Contact Person | Status |
|---|---|---|---|---|---|---|
| Small Cell Lung Cance (SCLC) | Chest Medicine | A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) | Phase III | Jen-Yu Hung | 董俞君 | On-going |
| Heart Failure | Cardiology | A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function | Phase III | Tsung-Hsien Lin | 江書瑜 | On-going |
| Hypertension | Cardiology | A Phase III, Randomised, Double -Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure | Phase III | Tsung-Hsien Lin | 江書瑜 | On-going |
| Heart Failure | Cardiology | A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure | Phase II | Tsung-Hsien Lin | 江書瑜 | On-going |
| 非 | Chest Medicine | A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 In Combination With Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer | Phase II | Chih-Jen Yang | 蔡詠翔 | On-going |
| Pulmonary Fibrosis | Chest Medicine | A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis | Phase III | Chau-Chyun Sheu | 鄭宇喬 | On-going |
| Pulmonary Fibrosis | Chest Medicine | An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease | Phase III | Chau-Chyun Sheu | 鄭宇喬 | On-going |
| Family Medicine | Multicentre, single-arm, non-interventional regulatory postmarketing surveillance (rPMS) study to evaluate the safety and effectiveness of SaxendaR for weight management in routine clinical practice in Taiwan | Phase IV | Chun-Ying Lee | On-going | ||
| Multiple Myeloma | Hematology and Oncology | EmplicitiR (elotuzumab) Post-marketing Surveillance Study for Patients with Multiple Myeloma in Taiwan | Phase IV | Hui-Hua Hsiao | 杜璧華 | On-going |
| Ophthalmology | A Study to Evaluate the Clinical Performance and Safety of Pegavision Silicone Hydrogel Monthly Disposable Soft Contact Lenses | Class II | Shiuh-Liang Hsu | On-going |
← Please slide to the left for more information